ReveraGen BioPharma (United States)
Open Access statistics for ReveraGen BioPharma (United States), United States, covering academic research published from 2012 to 2024.
Open Access statistics for ReveraGen BioPharma (United States), United States, covering academic research published from 2012 to 2024. Read More.
Open Access Percentage
73%
Total
Publications
51
Total Open
Publications
37
Total
Citations
1.2K
Open Access
Percentage
73%
Total
Publications
51
Total Open
Publications
37
Total
Citations
1.2K
Breakdown
Publisher Open
8%
Both
47%
Other Platform Open
18%
Closed
27%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 36%
10
Hybrid 36%
10
No Guarantees 28%
8
Other Platform Open
Domain 97%
32
Institution 27%
9
Public 9%
3
Other Internet 3%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 32 |
Europe PMC | Domain | 21 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 4 |
Newcastle Univesity - Newcastle University ePrints | Institution | 4 |
Semantic Scholar | Public | 3 |
Radboud University - Radboud Repository | Institution | 2 |
University of Padua - Padua Research Archive | Institution | 1 |
University of California - eScholarship University of California | Institution | 1 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 1 |
Ludwid Maxmilian's Universitat Munchen - Open access LMU | Institution | 1 |